23:28 , Oct 3, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Influenza virus Mouse studies suggest a vaccine based on multiple conformations of an HA1 epitope could help prevent influenza A infection. Crystallographic analyses of HA1 from four strains of influenza A virus identified five variant...
17:07 , Feb 6, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Influenza virus Mouse studies suggest a protein nanoparticle vaccine based on M2e, HA1 and HA2 could help prevent influenza A virus infection. The vaccine consists of a mixture of nanoparticles, all having the same protein...
00:30 , Oct 12, 2017 |  BC Innovations  |  Product R&D

Artificial mini proteins

Virvio Inc. has spun out of a group from the University of Washington to develop artificial mini proteins as novel influenza therapeutics. The mini proteins, typically ranging between 30 and 50 amino acids in length,...
16:20 , Jun 20, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Influenza virus In vitro, cell culture and mouse studies suggest the frog skin peptide urumin could help treat HA1-expressing influenza viral infection. In in vitro electron microscopy experiments, urumin decreased virion integrity of an HA1-expressing...
07:00 , Aug 23, 2012 |  BC Innovations  |  Targets & Mechanisms

Broader is better

A team from the Crucell Vaccine Institute and The Scripps Research Institute has identified a trio of neutralizing human mAbs that protect mice from challenge with influenza viruses, including one mAb that protects against both...